Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
27.11
-0.43 (-1.56%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Collegium Pharmaceutical Employees
Collegium Pharmaceutical had 423 employees as of December 31, 2025. The number of employees increased by 66 or 18.49% compared to the previous year.
Employees
423
Change (1Y)
66
Growth (1Y)
18.49%
Revenue / Employee
$1,910,657
Profits / Employee
$113,274
Market Cap
882.58M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 423 | 66 | 18.49% |
| Dec 31, 2024 | 357 | 160 | 81.22% |
| Dec 31, 2023 | 197 | -10 | -4.83% |
| Dec 31, 2022 | 207 | 55 | 36.18% |
| Dec 31, 2021 | 152 | -82 | -35.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evotec SE | 4,461 |
| Tilray Brands | 3,595 |
| Phibro Animal Health | 2,475 |
| Amphastar Pharmaceuticals | 1,976 |
| Pacira BioSciences | 829 |
| Cronos Group | 610 |
| Glass House Brands | 426 |
| Harrow | 373 |
COLL News
- 3 days ago - Collegium Pharmaceutical price target lowered to $48 from $56 at Barclays - TheFly
- 9 days ago - Collegium Announces $50 Million Accelerated Share Repurchase Program - GlobeNewsWire
- 16 days ago - Collegium Pharmaceutical Earnings Call Transcript: Q2 2026 - Transcripts
- 16 days ago - Collegium Pharmaceutical Quarterly report: Q2 2026 - Filings
- 16 days ago - Collegium Pharmaceutical Earnings release: Q2 2026 - Filings
- 16 days ago - Collegium Pharmaceutical Slides: Q2 2026 - Filings
- 16 days ago - Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress - GlobeNewsWire
- 4 weeks ago - Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026 - GlobeNewsWire